Latest round

Series C

Last raised

Dec 2022

Total raised

Undisclosed

Investors

8

About Mygene

Based in Guangzhou, China, and established in 2015, Mygene operates as a medical solution provider that offers tumor detection services for users through utilizing gene-sequencing technology, with a third-party medical testing laboratory in Guangzhou. In December 2019, it reached an IVD partnership agreement with Illumina. In April 2017, the Silicon Valley R&D Center was completed. The Chief Scientist Officer, Chunlin Wang, graduated from Stanford University. The company's genetic testing services can be categorized into lung cancer, colorectal cancer, breast cancer, gastrointestinal mesenchymal tumor, parenchymal tumor, childhood tumor, and prostate cancer.

Who invested in Mygene

8 investors across 3 rounds

See all investors in Mygene

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Dec 29, 2022

    Amount

    Undisclosed

    Investors

    Locked

  2. Series B

    Dec 29, 2019

    Amount

    Undisclosed

    Investors

    Locked

  3. Series A

    Apr 26, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about Mygene

Who invested in Mygene?

Mygene has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Mygene raised?

Mygene has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Mygene last raise money?

Mygene's most recent round on record is a Series C, in Dec 2022.

What does Mygene do?

Based in Guangzhou, China, and established in 2015, Mygene operates as a medical solution provider that offers tumor detection services for users through utilizing gene-sequencing technology, with a third-party medical testing laboratory in Guangzhou.

Where is Mygene headquartered?

Mygene is headquartered in Guangzhou, China.

Which VCs invest in companies like Mygene?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Mygene's stage. Their profiles are linked below.

Raising like Mygene? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.